Cancer Center Support Grant

摘要 在过去的5年里，该中心在癌症研究方面保持了卓越的发展轨迹，并为 它的集水区，北卡罗来纳州。随着夏普莱斯博士被任命为NCI主任，在 与大学领导层和中心的科学顾问协商后，Earp博士再次被任命为北卡罗来纳大学 莱恩伯格综合癌症中心(LCCC)主任连任。LCCC继续其 过去十年在包括国家服务在内的所有重要指标方面的出色表现。直接 2019年癌症研究成本资金增加到1.61亿美元，其中超过5400万美元来自NCI中心； 主任授权下的研究空间增加了约10 000 nsf；参与干预试验 在5年期间超过11,000项应计项目；在6,000多项与癌症有关的出版物中，36%是 协作；开始建设GMP设施，并启动了具有多个IND的CAR T计划 和8个审判开始；社区外联参与办公室扩大了LCCC的传统实力 参与以社区为基础的参与性研究和实施。 该中心的324名成员涵盖基础、临床和人口科学，分为9个项目，其中包括 大幅度提高方案间和方案内的生产率。物理和药学方面的教员增加 科学在药物发现、传递、成像和早期检测方面创造了新的机会。相当可观 对教师、技术和生物信息学的投资极大地扩大了癌症遗传学研究，包括 在TCGA方面处于领先地位，并在临床试验中扩大测序的使用。LCCC人口科学家发起 在癌症结果方面做出了重大的新努力，招募和建立了分析#年所有癌症病例的基础设施 我们的集水区，以及在癌症传播、健康获取、生存和治疗方面的新努力 分子流行病学。乳腺癌少数差异研究出现了开创性的观察结果 来自中心程序。我们的基本节目继续发布高影响力的观察结果，这些观察结果 转化为人类疗法。一项跨中心的全球肿瘤学工作在NCI的每一个项目上都获得了拨款 新的竞争。该中心的持续扩张是由出色的机构支持推动的，包括 州立法机构对癌症研究的直接支持。北卡罗来纳州大学莱恩伯格分校要求继续提供资金 用于：9个科学计划；13个共享资源；临床方案和数据管理；方案审查和 监测系统，发展资金，规划，领导和评估以及癌症研究和 职业提升CCSG预算支持人才的技术和运营扩展 通过癌症中心机制整合教职员工，以期在早期预防方面取得进展 在北卡罗来纳州和全国检测和治疗癌症。

ABSTRACT Over the past 5 years, the Center sustained its upward trajectory in cancer research excellence and service to its catchment area, the State of North Carolina. With Dr Sharpless’s appointment to NCI Director, in consultation with University leadership and the Center’s Scientific Advisors, Dr Earp was re-appointed UNC Lineberger Comprehensive Cancer Center (LCCC) Director for an additional term. The LCCC continued its exceptional performance of the past decade with respect to all important metrics including state service. Direct cost cancer research funding in 2019 increased to $161M of which over $54M comes from NCI; Center research space under the Director’s authority increased by ~10,000nsf; participation in interventional trials was over 11,000 accruals for the 5 year period; 36% of the more than 6,000 cancer related publication were collaborative; construction of a GMP facility was begun and a CAR T program was initiated with multiple INDs and 8 trials opened; and the Office of Community Outreach Engagement expanded LCCC’s traditional strength in community-based participatory research and implementation . The Center’s 324 members span the basic, clinical and population sciences organized into 9 programs with substantial inter- and intra-programmatic productivity. Faculty additions in the physical and pharmaceutical sciences created new opportunities in drug discovery, delivery, imaging and early detection. Substantial investment in faculty, technology and bioinformatics dramatically expanded cancer genetics research including leadership in the TCGA and expanded use of sequencing in clinical trials. LCCC population scientists initiated significant new efforts in cancer outcomes with recruitment and infrastructure for analyzing all cancer cases in our catchment area, as well as new endeavors in cancer communication, health access, survivorship and molecular epidemiology. Groundbreaking observations in breast cancer minority disparity research emerged from Center programs. Our basic programs continue to publish high-impact observations that are being translated into human therapeutics. A trans-Center Global Oncology effort received grants in each of the NCI’s new competitions. The Center’s continued expansion is driven by remarkable institutional support including direct support for cancer research from the state legislature. The UNC Lineberger requests continued funding for: 9 scientific programs; 13 shared resources; Clinical Protocol and Data Management; Protocol Review and Monitoring System, Developmental Funds, Planning, Leadership and Evaluation and Cancer Research and Career Enhancement The CCSG budget supports technological and operational expansion for a talented faculty integrated through cancer center mechanisms towards making advancements in the prevention, early detection, and treatment of cancer in North Carolina and the nation.